Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Specimen Collection Protocol for the Performance Evaluation of the Septin 9 Assay

NCT01329718 is registered in ClinicalTrials.gov with Epigenomics, Inc as lead sponsor.

NCT NCT01329718
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01329718 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Specimen Collection Protocol for the Performance Evaluation of the Septin 9 Assay
Lead sponsor
Epigenomics, Inc
Phase
Phase 1
Overall status
Completed
Start date
May 31, 2011
Completion date
December 31, 2012
Enrollment
562 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer